Open AccessValidation and Pilot Testing of a Guide to Measure the Costs Associated with the Management of COVID-19 and of Healthcare Associated Infections in Residential and Long-Term Care Facilities in Quebec
Author(s) -
Éric Tchouaket,
Stéphanie Robins,
Drissa Sia,
Josiane Létourneau,
Roxane Borgès Da Silva,
Kelley Kilpatrick,
Idrissa Beogo,
Natasha Parisien,
Sandra Boivin
Publication year - 2021
Publication title -
science of nursing and health practices
Language(s) - English
Resource type - Journals
ISSN - 2561-7516
DOI - 10.7202/1077991ar
Subject(s) - delphi method , covid-19 , pandemic , health care , test (biology) , protocol (science) , medicine , medical emergency , business , operations management , computer science , engineering , alternative medicine , political science , disease , paleontology , pathology , artificial intelligence , infectious disease (medical specialty) , law , biology
: As elsewhere in the world, Quebec (Canada) iscurrently facing the COVID-19 pandemic. Approximately 92% of deaths have occurred amongpeople aged over 70, and approximately 100 long-term care (LTC) centers (termed CHSLDs inQuebec) were contaminated. This alarming situation is prompting stakeholders from healthcarenetworks to investigate the socio-economic repercussions of COVID-19. To the best of ourknowledge, there is no valid and reliable tool to measure the costs associated with themanagement of COVID-19 in CHSLDs. Objectives : This research protocol aimsto: i) adapt and validate for use in CHSLDs a combined guide, Cout-COVID19-SLD, developedfrom 2 guides used in acute care; ii) pilot the Cout-COVID19-SLD guide in CHSLDs and testits feasibility and afterwards resolve any barriers to its administration, and to conduct apartial estimate of costs brought about by COVID-19. Methods : A two-partprospective study will be conducted. Phase 1 will use a Delphi approach with 14 to 17experts to validate the content of the Cout-COVID19-SLD guide. Phase 2 will pilot test theguide in a cross-sectional study in two CHSLDs. Discussion and conclusion :This study will provide a validated guide for the systematic measurement of costs associatedwith the management of COVID-19 (costs of preventive measures and costs of illness) inCHSLDs. Finally, this guide will serve as a valid and reliable instrument with which tobetter plan future research surrounding the socio-economic impacts of COVID-19 inCHSLDs.